Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study Evaluating Health Related Utility in Rheumatoid Arthritis

This study has been completed.
Sponsor:
Information provided by:
Wyeth is now a wholly owned subsidiary of Pfizer
ClinicalTrials.gov Identifier:
NCT00471874
First received: May 8, 2007
Last updated: December 11, 2007
Last verified: December 2007
  Purpose

The purpose of this study is to determine in Australia what effect rheumatoid arthritis has on quality of life, and also to determine the costs that are associated with having rheumatoid arthritis.


Condition
Rheumatoid Arthritis

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: An Observational Study to Examine the Relationship Between Rheumatoid Arthritis Disease Severity and Health Related Utility

Resource links provided by NLM:


Further study details as provided by Wyeth is now a wholly owned subsidiary of Pfizer:

Estimated Enrollment: 250
Study Start Date: April 2007
Study Completion Date: December 2007
Detailed Description:

At a routine visit to the clinic, patients will be asked to answer questions about their symptoms, have a routine examination by the doctor, fill out a questionnaire that will ask questions about them, about their arthritis, about how it affects their well being and quality of life, and about treatment and costs. The questionnaire will take them about 30 minutes to complete. A blood test may also be required.

This ends the patient's involvement with the study.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Male or female patient with clinically defined rheumatoid arthritis diagnosed for at least 3 months
  • Age 18 years or older
  • Ability to complete the study documents in English

Exclusion Criteria:

· Current participation in a blinded trial of an investigational treatment

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00471874

Locations
Australia, New South Wales
Darlinghurst, New South Wales, Australia, 2010
Wollongong, New South Wales, Australia, 2500
Australia, Queensland
Maroochydore, Queensland, Australia, 4558
Australia, Victoria
Malvern, Victoria, Australia, 3144
Sponsors and Collaborators
Wyeth is now a wholly owned subsidiary of Pfizer
Investigators
Study Director: Medical Monitor Wyeth is now a wholly owned subsidiary of Pfizer
Principal Investigator: Trial Manager For Australia, medinfo@wyeth.com
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00471874     History of Changes
Other Study ID Numbers: 0881X1-4427
Study First Received: May 8, 2007
Last Updated: December 11, 2007
Health Authority: Australia: Human Research Ethics Committee

Additional relevant MeSH terms:
Arthritis
Arthritis, Rheumatoid
Autoimmune Diseases
Connective Tissue Diseases
Immune System Diseases
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on November 23, 2014